|
Stu Chalmers Carcinoid Story - continued
November 2002
Chromagranin A started to rise, and was having some breakthrough
diarrhea. Dr. Pommier accelerated me to higher dosage of Sandostatin.
My LAR dosage was increased from 20 LAR to 60 LAR in 11 months.
The increased LAR seemed to stall the Chromagranin A from going
higher; but it had already trended from around 50 to around 200.
For practical purposes I will attach the graph that I made of CgA
and 5HIAA against time with specific data around the levels of Sandostatin
LAR. I show this because I believe very strongly that each of us
should take the data that we receive from this testing, document
it and show trends. The reason is that every time a test is performed,
the oncologist can see the single datapoint, but if we graph the
data to show a trend, we can see and show the oncologist what is
going on.
March 2004 my Chromagranin A shot up to 1700; note that 5HIAA did
not change appreciably. I immediately talked to Dr. Pommier. He
asked for a CT scan and the trend chart. We sent that to him and
based upon CT scans his opinion was that the liver needed some major
intervention and started his Chemo infusion to Chemo embolization
protocol in May. I went to Portland each month from May through
August. We decided not to do the CE part due to holidays and a grandchild
due in October, with Dr. Pommier agreeing to do the CE in January
2005.
Below I include a photograph of the port as they took it out in
early September. The port is placed just under the rib cage and
is connected to the ribs with some special string to keep it in
place when they access it to put in the 5FU. When the port was taken
out a couple of High School students interested in medicine were
allowed to watch and I had them take some snap shots during the
process. The port itself has an access membrane that is about the
size of a Quarter, just to give a frame of reference for size. A
complete write up of what Dr. Pommier does is included in the Carcinoid
conference from the 2003 October conference in Santa Ana, CA. The
transcript of his talk is available on the Carcinoid website that
Dr. and Mrs. Warner keep up.

October 2004
Began to have a lot of abdominal pain. Dr. Pommier asked for another
CT scan and Octreoscan, resulting in him being more concerned with
my Peritoneal disease than liver disease. The CT scan was showing
the mets to my mesentery. Dr. Pommier indicated that when he put
in the port in May he noticed that the sesame seed sized mets were
now the size of peas and lentils. His advice was that I had several
options. One was to do surgery to remove the adhesions and as many
of the peritoneal mets as possible. However the downside of this
was I was losing weight and recovery might be very difficult after
a 12 hour surgery. The second option was to have the treatments
with radioisotopes being done in Europe. We discussed Rotterdam,
Milan and Basel and decided upon Basel. Dr. Pommier has referred
patients to them before and is very comfortable with their expertise
and process. Dr. Pommier began conversing with Basel folks in late
December once he had my Octreoscan. They will only consider a patient
that has had an Octreoscan which shows a lot of positive uptake
as well as a healthy kidney function.
January - 2005
In lots of pain, taking pain meds. Dr. Kneifel from Basel contacted
me and indicated that the treatment has to be 60 days minimum from
last LAR shot. When LAR wears off take sub Q, then nothing for 72
hours before treatment. He had to look at blood work and also get
electronic copies of Octreoscans before agreeing to treat me. Finally
we set the date of the first of two treatments to be on March 7.
I will leave Austin March 4 and return on March 11. My second treatment
will most likely be in June time frame to fit my schedule, Basel's
schedule and allow the body to recover from the trauma of the treatment.
Most of the literature on this subject shows before and after about
1 year apart, so the process of radiation is aggressive right away,
but continues on with results for several months. There are some
great reports on the subject available in PDF file, but they are
very technical. In the process of working on the Basel treatment
as an alternative I found great testimonial information from Gary
Zhou and it is written for us Carcinoid types in laymans language.
If anyone is interested Gary Zhou from Denver went through the
same treatment last year and his emails can be pulled up from the
ACOR group archives. The Rotterdam option is also a good one. Kevin
Pyle has written quite a bit about his experience and it is available
in the ACOR archives. Both Kevin and Gary have been supportive in
responding to emails and taking phone calls. At this time Rotterdam
only does the Lutetium 177 whereas Basel does both Lu 177 and Yttrium
90. Dr. Kneifel in Basel told me that the first treatment that I
will get will be with the Yttrium 90 and just prior to my second
treatment they will assess with Scintigraphy (Octreoscan) and may
use more Y-90 or a cocktail of Yttrium and Lutetium.
Once I have gone through the process and see/feel the results I
will try to write this information up and make it accessible to
CCTS as well as Susan Andersons site.
God has been faithful, giving me hope and the strength through
this whole ordeal. I have been able to work full time, then part
time with disability and my colleagues have been very supportive.
My input is to drive your understanding with data; use a Carcinoid
specialist coordinated with a local oncologist and when the markers
and your body are telling you that something has changed insist
on doing something different. I dont know how long I will
last; 1 year or 15 years, but either way it is also comforting to
know that there is support through fellow carcinoids, doctors and
from friends and family.
|